Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment-resistant Depression (TRD)”

106 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 106 results

Post-approval studies (Phase 4)Study completedNCT02977299
What this trial is testing

Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-responders With TRD

Who this might be right for
Treatment Resistant Major Depressive Disorder
Massachusetts General Hospital 278
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07210112
What this trial is testing

Efficacy of Psilocybin and Trazodone Combination in Treatment-resistant Depression: a Randomized Controlled Proof-of-concept Study (PSILOTRAZ)

Who this might be right for
Depression - Major Depressive DisorderTreatment-resistant Depression (TRD)
Centre Hospitalier St Anne 112
Not applicableLooking for participantsNCT04080778
What this trial is testing

Magnetic Seizure Therapy in Bipolar Depression (MST-BpD) and Treatment Resistant Depression (MST-TRD)

Who this might be right for
Bipolar Disorder
Joao L. DeQuevedo 60
Not applicableStudy completedNCT06372834
What this trial is testing

Adjuvant Accelerated piTBS for Reducing Suicidal Ideation in TRD Patients

Who this might be right for
Major Depressive DisorderTreatment-Resistant DepressionSuicide Ideations
Tri-Service General Hospital 100
Large-scale testing (Phase 3)UnknownNCT02383693
What this trial is testing

Maintenance rTMS for Treatment-resistant Depression (TRD): a One-year Double Blind Controlled Study

Who this might be right for
Major Depressive Disorder
Centre hospitalier de Ville-Evrard, France 40
Not applicableStudy completedNCT03642522
What this trial is testing

Investigating Predictors of Treatment Response in Treatment-Resistant Depression (TRD) With Interleaved TMS/fMRI

Who this might be right for
Major Depressive DisorderDepression
University of British Columbia 72
Not applicableLooking for participantsNCT03887715
What this trial is testing

A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression

Who this might be right for
Treatment Resistant Depression
LivaNova 6,800
Not applicableEnded earlyNCT04753385
What this trial is testing

The RECOVER sUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will providE Assessment measuRes for Depressive Episodes

Who this might be right for
Treatment Resistant Depression
LivaNova 138
Not applicableStudy completedNCT03068715
What this trial is testing

Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression (SAINT-TRD)

Who this might be right for
Treatment Resistant Depression
Stanford University 30
Large-scale testing (Phase 3)Study completedNCT02741791
What this trial is testing

Assess the Efficacy and Safety of AXS-05 in Subjects With Treatment Resistant Major Depressive Disorder

Who this might be right for
Treatment Resistant Major Depressive Disorder
Axsome Therapeutics, Inc. 312
Testing effectiveness (Phase 2)Study completedNCT01920555
What this trial is testing

Double-Blind, Placebo-Controlled Trial of Ketamine Therapy in Treatment-Resistant Depression (TRD)

Who this might be right for
Treatment Resistant Depression
Massachusetts General Hospital 99
Testing effectiveness (Phase 2)Study completedNCT01369095
What this trial is testing

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Who this might be right for
Depression
Bristol-Myers Squibb 976
Not applicableNot Yet RecruitingNCT06542900
What this trial is testing

Efficacy of Deep Brain Stimulation(DBS) for Treatment-Resistant Depression(TRD)

Who this might be right for
Treatment Resistant Depression
Xuanwu Hospital, Beijing 60
Testing effectiveness (Phase 2)Study completedNCT05414422
What this trial is testing

A Randomized, Placebo-Controlled, Double-Blind Study to Assess Safety and Efficacy of PCN-101 in TRD

Who this might be right for
Treatment Resistant Depression
Perception Neuroscience 102
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07287839
What this trial is testing

Parcel-guided rTMS for Major Depressive Disorder

Who this might be right for
Treatment Resistant Depression (TRD)
Soterix Medical 60
Large-scale testing (Phase 3)Looking for participantsNCT07088380
What this trial is testing

Ketamine Augmentation of ECT in Treatment-Resistant Depression

Who this might be right for
Major Depressive DisorderTreatment Resistant Depression
Università Vita-Salute San Raffaele 30
Post-approval studies (Phase 4)Looking for participantsNCT07369102
What this trial is testing

Esketamine With or Without Integration Therapy for Treatment-Resistant Depression

Who this might be right for
Treatment-resistant Depression (TRD)
University of Puerto Rico 20
Testing effectiveness (Phase 2)Study completedNCT00768430
What this trial is testing

Optimization of IV Ketamine for Treatment Resistant Depression

Who this might be right for
Major Depressive Disorder (MDD)Treatment Resistant Depression (TRD)
Baylor College of Medicine 73
Not applicableLooking for participantsNCT03320304
What this trial is testing

Assess Effectiveness and Efficiency of VNS Therapy in Patients With Difficult to Treat Depression.

Who this might be right for
Treatment Resistant Depression
LivaNova 500
Testing effectiveness (Phase 2)Study completedNCT05454410
What this trial is testing

Study of Efficacy, Safety, Tolerability and Pharmacokinetics of MIJ821 in Participants With Treatment- Resistant Depression (TRD)

Who this might be right for
Treatment-Resistant Depression
Novartis Pharmaceuticals 60
Load More Results